SCHEMBL5194875

SCHEMBL5194875

CN1C(=O)C(=NO)c2ccccc21

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 5/20 0.65
LRRK2 Q5S007 1/20 0.59
CES1 P23141 1/20 0.58
MAPT P10636 6/20 0.58
RAB9A P51151 2/20 0.58
MAPK1 P28482 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
KMT2A Q03164 6/20 0.57
ALDH1A1 P00352 5/20 0.57
HPGD P15428 3/20 0.57
F2 P00734 1/20 0.57
ATM Q13315 1/20 0.57
CA1 P00915 2/20 0.52
CA2 P00918 2/20 0.52
CA12 O43570 1/20 0.52
CA9 Q16790 1/20 0.52
HSP90AA1 P07900 2/20 0.52
TRPA1 O75762 1/20 0.50
NPC1 O15118 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5194860 1.00 TTR (0.65) TTRLRRK2CES1MAPTRAB9A
SCHEMBL9587996 0.89 TTR (0.65) TTRLRRK2CES1MAPTRAB9A
SCHEMBL11831457 0.89 TTR (0.65) TTRLRRK2CES1MAPTRAB9A
SCHEMBL9587991 0.89 TTR (0.65) TTRLRRK2CES1MAPTRAB9A
SCHEMBL25136853 0.83 TTR (0.67) TTRLRRK2CES1MAPTRAB9A
SCHEMBL13114100 0.83 TTR (0.67) TTRLRRK2CES1MAPTRAB9A
SCHEMBL13994611 0.81 TTR (0.65) TTRLRRK2CES1MAPTRAB9A
SCHEMBL21999876 0.81 TTR (0.65) TTRLRRK2CES1MAPTRAB9A
SCHEMBL7100709 0.81 TTR (0.65) TTRLRRK2CES1MAPTRAB9A
SCHEMBL9182801 0.79 KMT2A (0.45) TTRLRRK2CES1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1707187-B1 Reductive colorant for keratin fibres WELLA AG (DE) 2007-08-01 EP claimed
US-20060230548-A1 Reductive colorant for keratin fibres THE PROCTER & GAMBLE COMPANY 2006-10-19 US claimed
EP-1707187-A1 Reductive colorant for keratin fibres Wella Aktiengesellschaft (DE) 2006-10-04 EP claimed
WO-2004039409-A2 COMPOSITION COMPRISING ACTIVATORS OF IK POTASSIUM CHANNELS AND CALCINEURIN ANTAGONISTS AND USE THEREOF SWITCH BIOTECH AG (DE) 2004-05-13 WO claimed
CN-118638104-A Synthesis and application of indolone lactone analogue with oxime ether linkage 南开大学 2024-09-13 CN disclosed
EP-1707187-B1 Reductive colorant for keratin fibres WELLA AG (DE) 2007-08-01 EP disclosed
US-20060230548-A1 Reductive colorant for keratin fibres THE PROCTER & GAMBLE COMPANY 2006-10-19 US disclosed
WO-2006107595-A1 REDUCTIVE COLORANT FOR KERATIN FIBRES THE PROCTER & GAMBLE COMPANY (US) 2006-10-12 WO disclosed
EP-1707187-A1 Reductive colorant for keratin fibres Wella Aktiengesellschaft (DE) 2006-10-04 EP disclosed
US-5364617-A Protection from solar radiation, chelate with iron in body and reduce its ability to catalyze formation of oxygen free radicals THE PROCTER & GAMBLE COMPANY (US) 1994-11-15 US disclosed
EP-0611301-A1 CHELATOR COMPOSITIONS COMPRISING OXIME COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 1994-08-24 EP disclosed
EP-0611301-A4 CHELATOR COMPOSITIONS COMPRISING OXIME COMPOUNDS. PROCTER & GAMBLE (US) 1993-03-01 EP disclosed
WO-1991016034-A1 CHELATOR COMPOSITIONS COMPRISING OXIME COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 1991-10-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060230548-A1 Reductive colorant for keratin fibres KRT18, COX6C, CYC1 TTR 654/4885LRRK2 3974/4885CES1 3409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.